Lisa Lohmann
Muenster, NW 48149, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Journal: Science translational medicine
Published: March 27, 2024
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Journal: Annals of neurology
Published: September 08, 2023
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients.
Journal: Clinical and translational science
Published: January 20, 2022
Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
Journal: BMC neurology
Published: December 20, 2021
Neuromyelitis Optica Spectrum Disorders - Present Insights and Recent Developments
Journal: Fortschritte der Neurologie-Psychiatrie
Published: October 19, 2021
Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: March 05, 2021
Status of clinical research in neurology in Germany-A national survey.
Journal: European journal of neurology
Published: December 06, 2020
Classification of neurological diseases using multi-dimensional CSF analysis.
Journal: Brain : a journal of neurology
Published: December 01, 2020
Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis.
Journal: Journal of neuroimmunology
Published: November 11, 2019
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid-Results from the ToFingo Successor Study.
Journal: Frontiers in immunology
Published: April 06, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026